Cancer is the leading cause of death in the western industrialized world. There is a strong demand world-wide for innovative and patient friendly cancer therapy solutions.
LIONESS Light Ions combine medical technology innovations with unique know-how to offer the solutions needed to treat cancer with particle therapy, in the most efficient and human friendly ways.
LIONESS Light Ions is a private corporation currently active in Japan, Switzerland, Sweden, UK, France, the Netherlands, Italy, Spain, Belgium, Germany, USA and Canada. The people behind LIONESS bring a wealth of experience and ideas for the advanced radiation therapy markets.
LIONESS Light Ions are poised to redefine efficiencies for hospitals and cancer patients globally.